Page 3 - Best Leukemia chemotherapy doctors: TOP 97 doctors

Dr. Alemdar specializes in leukemia chemotherapy with extensive training at Akdeniz University Hospital, a leading oncology center.

• Board-certified in medical oncology with over 20 years of experience of experience
• Worked at multiple prestigious hospitals including Akdeniz University Hospital
• Specialized in internal medicine before focusing on oncology

Dr. Eckhart Weidmann heads the Hematology sector at Nordwest Clinic, specializing in blood disorder treatment with over 36 years of experience of practice.

• One of the best non-Hodgkin lymphoma doctors
• Professor with extensive academic and clinical expertise
• Focuses on leukemia and other blood disorders

Israel's leading specialist in lung cancer immunotherapy – Prof. Peled heads the Thoracic Cancer Unit at Davidoff Cancer Center.

• Expert in personalized medicine and immuno-oncology
• Recipient of ASCO's MERIT award for lung cancer research
• Chair of IASLC's Early Detection & Prevention Committee
• Fellowship-trained at University of Colorado Denver

Professor Bosch is a globally recognized leader in Chronic Lymphocytic Leukemia (CLL), pioneering new treatments and technologies for hematological diseases.

• Over 126 years of experience of experience in hematology, specializing in lymphomas and CLL
• Leads clinical trials from phase 1 to phase 3, bringing new therapies to patients
• Head of Hematology at IOB Institute of Oncology and Vall d'Hebron University Hospital
• Published 100+ articles in top journals like The New England Journal of Medicine

Dr. Danylesko specializes in leukemia chemotherapy at Sheba Medical Center, a leading oncology facility.

Dr. Mahmoud M. El Zembely is a pediatric oncologist and malignant hematologist. He manages acute lymphoblastic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. He treats Hodgkin and non‑Hodgkin lymphomas, nephroblastoma, neuroblastoma, and bone and liver tumors. His work includes gonadal and extragonadal germ cell tumors, rhabdomyosarcoma, and non‑rhabdomyosarcoma soft tissue sarcomas. He also cares for rare cancers and survivorship.

Accreditations: M.B.B.Ch, Assiut University, 2006. Master’s in Pediatric Oncology and Malignant Hematology, 2011. Clinical fellowship in pediatric bone marrow transplantation, Seattle Cancer Care Alliance, 2015–2017. Doctorate, 2020.

Roles: South Egypt Cancer Institute–Assiut University: Pediatric Oncology, 2008–2012. Assistant Lecturer, 2012–2019. Lecturer, 2020–2024. Shefa Al‑Orman Cancer Center, Luxor: Head of Pediatric Oncology, 2020–present.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Prof. Myriam Ben Arush, an internationally recognized specialist in Pediatric Oncology, directs the Pediatric Division at Ruth Rappaport Children's Hospital.

• Recipient of the Ministry of Health Prize for outstanding work
• Awarded the Chevalier de la Legion d'Honneur in France
• Recognized as one of the world's most caring doctors by the World Medical Association
• Member of the children's oncology group in the USA and several European cancer societies

Radiotherapy specialist focused on leukemia chemotherapy – Dr. Drumea brings targeted expertise to Rambam Medical Center.

• Oncologist with a focus on precise cancer treatment
• Uses advanced radiotherapy techniques
• Works at Rambam Medical Center – a leading Israeli hospital

Head of Hematology at Hadassah Medical Center – Professor Ben-Yehuda specializes in molecular diagnostics and gene therapy for blood cancers.

• Trained at Memorial Sloan-Kettering Cancer Center in New York
• First woman to lead Hadassah School of Medicine
• Recipient of the Healing with the Heart Award for exceptional patient care
• Member of International Society of Hematology and Hemato-Oncology

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Spielberg specializes in leukemia chemotherapy at Assuta Medical Center.

• Oncohematologist with a focus on blood cancers
• Works at one of Israel's leading medical centers
• Provides personalized treatment plans for leukemia patients

Chief Physician of the Oncology Center at Assuta Medical Center – a leader in cancer care with a focus on leukemia treatment.

• Oncologist specializing in chemotherapy protocols
• Handles complex leukemia cases at a top-tier medical center
• Leads the Oncology Center's treatment programs

Dr. Kim specializes in oncology and gynecology, offering expert care at Samsung Medical Center.

• Focuses on oncogynecological treatments
• Works at a top-tier medical facility
• Provides specialized care for complex cases

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.